2025年1月24日乳腺癌文献精选

学术   2025-01-24 15:35   上海  


Nat Cancer. 2025 Jan 23. IF: 23.5

Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells.

www.nature.com/articles/s43018-024-00889-9


JAMA Oncol. 2025 Jan 23. IF: 22.5

Critical Review on Breast Cancer Research.

www.jamanetwork.com/journals/jamaoncology/fullarticle/2829413


JAMA Oncol. 2025 Jan 23. IF: 22.5

Critical Review on Breast Cancer Research-Reply.

www.jamanetwork.com/journals/jamaoncology/fullarticle/2829412


Nat Mach Intell. 2025 Jan 23;7:29-42. IF: 18.8

Moving towards genome-wide data integration for patient stratification with Integrate Any Omics.

www.nature.com/articles/s42256-024-00942-3


Lancet Reg Health Eur. 2025 Jan 23;49:101212. IF: 13.6

Dose-dense anthracycline- and taxane-based chemotherapy remains the preferred treatment for selected patients with high-risk early breast cancer.

www.sciencedirect.com/science/article/pii/S2666776225000043


Small. 2025 Jan 23. IF: 13.0

A Self-Amplifying Photodynamic Biomedicine for Cascade Immune Activation Against Triple-Negative Breast Cancer.

www.onlinelibrary.wiley.com/doi/10.1002/smll.202410214


Adv Healthc Mater. 2025 Jan 23. IF: 10.0

Endogenous Protein-Modified Gold Nanorods as Immune-Inert Biomodulators for Tumor-Specific Imaging and Therapy.

www.onlinelibrary.wiley.com/doi/10.1002/adhm.202404548


J Exp Clin Cancer Res. 2025 Jan 23;44(1):21. IF: 11.4

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.

www.biomedcentral.com/articles/10.1186/s13046-025-03294-x


Carbohydr Polym. 2025 Mar 15;352:123162. IF: 10.7

Bioinspired complex cellulose nanorod-architectures: A model for dual-responsive smart carriers.

www.sciencedirect.com/science/article/pii/S0144861724013882


Carbohydr Polym. 2025 Mar 15;352:123201. IF: 10.7

Hyaluronan-decorated CuO(2)-doxorubicin nanodot clusters for targetedly sensitizing cuproptosis in breast cancer via a three-pronged strategy.

www.sciencedirect.com/science/article/pii/S0144861724014279


Eur J Surg Oncol. 2025 Jan 19;51(5):109620. IF: 3.5

Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey.

www.ejso.com/article/S0748-7983(25)00048-4/fulltext










































SIBCS
上海国际乳腺癌论坛(Shanghai International Breast Cancer Symposium)
 最新文章